New trial finds radiotherapy combined with hormone therapy can help some advanced prostate cancer patients avoid chemotherapy 08 May 2024 Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, according to researchers from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. Find out more Show/Hide
Her Majesty The Queen presents cancer researchers with prize at Buckingham Palace 22 Feb 2024 Earlier today, researchers from The Institute of Cancer Research, London, received a prestigious Queen’s Anniversary Prize on behalf of the institute, in recognition of its transformational breast cancer research programme. Find out more Show/Hide
Trial results support ‘new gold standard’ for head and neck cancer radiotherapy 22 Nov 2023 Phase 3 trial results on a precision radiotherapy technique support a ‘new gold standard’ for treating head and neck cancer patients. The research suggests the new approach can reduce the risk of swallowing problems after radiotherapy, without impacting the success of treatment. Find out more Show/Hide
High-performance computing facilitates new radiotherapy approach that could improve therapy for hard-to-treat cancers 30 Oct 2023
Higher doses of radiotherapy cut treatment time by up to 75 per cent in localised prostate cancer patients, while maintaining high cure rates 29 Sep 2023
Biological markers identified as powerful predictors of prostate cancer relapse following radiotherapy 04 Apr 2023